Privacy Policy
By clicking above, I agree to receive telephone calls and text messages at the telephone number provided above/below (including any mobile number provided). I understand that consent is not a condition to receive the services and that I may revoke my consent at any time. I also have read and agree to your Privacy Policy.
CHECK YOUR ELIGIBILITY FOR FREE BELOW
Depo-Provera Linked to Elevated Meningioma Risk
The Victims Are Stepping Up
Find Out If You Qualify for Compensation
Had at least two consecutive injections within a 12-month period.
Were given a generic equivalent of Depo-Provera in California, Massachusetts, or Tennessee.
CALL FOR A FREE CASE REVIEW
WE ARE HERE FOR YOU
OUR 3-STEP PROCESS PROTECTS YOUR PRIVACY
CONTACT US
Get compassionate support with a quick call or text.
TALK WITH OUR SPECIALISTS
Get a free, no-obligation case review with a simple and hassle-free process.
FILE YOUR CLAIM
Stay informed with regular updates and reliable support every step of the way.
By using this website, you consent to the use of Microsoft Clarity, a web analytics service provided by Microsoft Corporation, to collect information about your usage of our website. Microsoft Clarity uses cookies and other tracking technologies to collect data on your behavior, such as the pages you visit, the links you click, and the time you spend on our website. This information helps us improve our website and provide a better user experience for our visitors. The information collected by Microsoft Clarity is anonymous and does not personally identify you.
Developed meningioma or a brain tumor following these injections.
Received Depo-Provera or a generic equivalent in 2000 or later.
Diagnosed with Meningiomas (Brain Tumors) After Depo-Provera?
FREE CLAIM REVIEW
You may qualify for compensation if you or a loved one developed a meningioma (brain tumor) after using Depo-Provera or its generic equivalents.